TOVANOR

This brand name is authorized in Austria, Estonia, Spain, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, South Africa

Active ingredients

The drug TOVANOR contains one active pharmaceutical ingredient (API):

1 Glycopyrronium UNII H4S7L81L98 - CHLOROGLYCOPYRRONIUM BROMIDE

Glycopyrronium is an inhaled long-acting muscarinic receptor antagonist (anticholinergic) for once-daily maintenance bronchodilator treatment of COPD. Glycopyrronium works by blocking the bronchoconstrictor action of acetylcholine on airway smooth muscle cells, thereby dilating the airways. Read about Glycopyrronium

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TOVANOR BREEZHALER Inhalation powder, hard capsule	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03BB06		R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BB Anticholinergics
Discover more medicines within R03BB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1595819, 1595820, 1595831, 1595842, 1595853, 1595864, 1718478
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 112790003
Country: IT	Agenzia del Farmaco	Identifier(s): 042313015, 042313027, 042313039, 042313041, 042313054, 042313066, 042313078, 042313080
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1067958, 1067959, 1067960, 1067961, 1067962, 1067963, 1080802, 1080803
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 103942
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100315344
Country: ZA	Health Products Regulatory Authority	Identifier(s): 47/10.2.1/0120